A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients.

Juliana Muller BarkAvinash V KarpeJames D DoeckePaul LeoRosalind L JeffreeBenjamin ChuaBryan W DayDavid J BealeChamindie Punyadeera

Published in: Cancer medicine (2023)

Our findings indicate that changes in salivary and plasma metabolites in GBM patients can potentially be employed as less invasive prognostic biomarkers/biomarker panel but validation with larger cohorts is required.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported
single cell